90 related articles for article (PubMed ID: 2169441)
1. Effect of IL-6 on proliferation and IG production of human EBV-transformed cell lines in serum free culture media.
Jochems GJ; Jordens R; van Lier RA; Zeijlemaker WP
Dev Biol Stand; 1990; 71():57-63. PubMed ID: 2169441
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity in both cytokine production and responsiveness of a panel of monoclonal human Epstein-Barr virus-transformed B-cell lines.
Jochems GJ; Klein MR; Jordens R; Pascual-Salcedo D; van Boxtel-Oosterhof F; van Lier RA; Zeijlemaker WP
Hum Antibodies Hybridomas; 1991 Apr; 2(2):57-64. PubMed ID: 1651786
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
Tseng CT; Springgate CF; Piela TH; Choi YS
J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr-virus-transformed lymphoblastoid cell lines derived from patients with X-linked agammaglobulinaemia and Wiskott-Aldrich syndrome: responses to B cell growth and differentiation factors.
Lau YL; Shields JG; Levinsky RJ; Callard RE
Clin Exp Immunol; 1989 Feb; 75(2):190-5. PubMed ID: 2539277
[TBL] [Abstract][Full Text] [Related]
5. Development of a serum-free medium which supports the long-term growth of human and nonhuman primate lymphoid cells.
Brown RL; Griffith RL; Neubauer RH; Rabin H
J Cell Physiol; 1983 May; 115(2):191-8. PubMed ID: 6341383
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
Tosato G; Gerrard TL; Goldman NG; Pike SE
J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
[TBL] [Abstract][Full Text] [Related]
7. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines.
Mevissen ML; Kwekkeboom J; Goormachtig E; Lindhout E; de Groot C
Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865
[TBL] [Abstract][Full Text] [Related]
8. Lymphoblastoid B cell lines produce an interleukin-1-like activity that can be serologically distinct from macrophage interleukin-1.
Valentine M; Lotz M; Dinarello CA; Carson DA; Vaughan JH
Lymphokine Res; 1986; 5(3):173-83. PubMed ID: 3018386
[TBL] [Abstract][Full Text] [Related]
9. Relationship between immunoglobulin production and immortalization by Epstein Barr virus.
Tosato G; Blaese RM; Yarchoan R
J Immunol; 1985 Aug; 135(2):959-64. PubMed ID: 2989369
[TBL] [Abstract][Full Text] [Related]
10. Characterization of lymphokines mediating B cell growth and differentiation from monoclonal anti-CD3 antibody-stimulated T cells.
Sherris D; Stohl W; Mayer L
J Immunol; 1989 Apr; 142(7):2343-51. PubMed ID: 2538506
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C regulates secretion of lymphotoxin (LT/TNF beta) and TNF alpha by human EBV-transformed B cells.
Jochems GJ; Klein MR; Zeijlemaker WP; van Lier RA
Hum Antibodies Hybridomas; 1992 Oct; 3(4):162-7. PubMed ID: 1335785
[TBL] [Abstract][Full Text] [Related]
12. Monomeric IgG2 enhances Ig production and proliferation in human B cells.
Kimata H; Yoshida A; Ishioka C; Jiang Y; Kusunoki T; Mikawa H
Biotechnol Ther; 1993; 4(1-2):1-16. PubMed ID: 8374507
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory role of IL-4 on the secretion of Ig by human B cells.
Splawski JB; Jelinek DF; Lipsky PE
J Immunol; 1989 Mar; 142(5):1569-75. PubMed ID: 2493049
[TBL] [Abstract][Full Text] [Related]
14. The superoxide generating system of B cell lines. Structural homology with the phagocytic oxidase and triggering via surface Ig.
Maly FE; Cross AR; Jones OT; Wolf-Vorbeck G; Walker C; Dahinden CA; De Weck AL
J Immunol; 1988 Apr; 140(7):2334-9. PubMed ID: 2832475
[TBL] [Abstract][Full Text] [Related]
15. Expression of the IL-6 gene induces differentiation of a human monoclonal EBV-transformed B cell line.
Jochems GJ; Bende RJ; Klein MR; Zeijlemaker WP; van Lier RA
Hum Antibodies Hybridomas; 1993 Jul; 4(3):124-33. PubMed ID: 8395233
[TBL] [Abstract][Full Text] [Related]
16. Involvement of IL-10 in the autonomous growth of EBV-transformed B cell lines.
Beatty PR; Krams SM; Martinez OM
J Immunol; 1997 May; 158(9):4045-51. PubMed ID: 9126962
[TBL] [Abstract][Full Text] [Related]
17. Properties and heterogeneity of human fetal pre-B cells transformed by EBV.
Hui MF; Lam P; Dosch HM
J Immunol; 1989 Oct; 143(8):2470-9. PubMed ID: 2551960
[TBL] [Abstract][Full Text] [Related]
18. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
[TBL] [Abstract][Full Text] [Related]
19. Phenotype, frequency, and EBV responsiveness of human marrow B and pre-B cells.
Hibi T; Chan MA; Petsche D; Dosch HM
J Immunol; 1986 May; 136(9):3211-8. PubMed ID: 3007613
[TBL] [Abstract][Full Text] [Related]
20. B-cell-derived IL-10: production and function.
Burdin N; Rousset F; Banchereau J
Methods; 1997 Jan; 11(1):98-111. PubMed ID: 8990095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
